LINCOLN, Mass., Sept. 12, 2016 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug invention, today announced an agreement with Jounce Therapeutics for clinical pharmacology and quantitative systems pharmacology (QSP) modeling and simulation support for Phase 1 clinical trials.
Applied BioMath will:
- Work with the clinical and biomarker sub-teams at Jounce to support scientific aspects and implementation of the PKPD strategy in the Phase 1 trial
- Provide real time clinical pharmacology support including data analysis and visualization
- Author the PKPD analysis plan included in the final clinical study report